JP2023524996A5 - - Google Patents
Info
- Publication number
- JP2023524996A5 JP2023524996A5 JP2022567342A JP2022567342A JP2023524996A5 JP 2023524996 A5 JP2023524996 A5 JP 2023524996A5 JP 2022567342 A JP2022567342 A JP 2022567342A JP 2022567342 A JP2022567342 A JP 2022567342A JP 2023524996 A5 JP2023524996 A5 JP 2023524996A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- symptoms
- pharmaceutically acceptable
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063020041P | 2020-05-05 | 2020-05-05 | |
| US63/020,041 | 2020-05-05 | ||
| PCT/US2021/030540 WO2021226002A1 (en) | 2020-05-05 | 2021-05-04 | Small molecule inhibitors of galectin-3 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524996A JP2023524996A (ja) | 2023-06-14 |
| JP2023524996A5 true JP2023524996A5 (https=) | 2024-05-16 |
| JP7705884B2 JP7705884B2 (ja) | 2025-07-10 |
Family
ID=76076509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567342A Active JP7705884B2 (ja) | 2020-05-05 | 2021-05-04 | ガレクチン－３の低分子阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12275720B2 (https=) |
| EP (1) | EP4146646A1 (https=) |
| JP (1) | JP7705884B2 (https=) |
| KR (1) | KR20230006547A (https=) |
| CN (1) | CN115551855A (https=) |
| WO (1) | WO2021226002A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2631509A (en) * | 2023-07-04 | 2025-01-08 | Univ Liverpool | Compositions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| ES2652488T3 (es) | 2009-04-28 | 2018-02-02 | Galecto Biotech Ab | Nuevos inhibidores de galactósidos de galectinas |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| CA3000924A1 (en) | 2015-11-09 | 2017-05-18 | Galecto Biotech Ab | Novel galactoside inhibitors of galectins |
| KR20200015528A (ko) | 2017-05-12 | 2020-02-12 | 갈랙틴 사이언시즈, 엘엘씨 | 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도 |
| EP3621973A4 (en) | 2017-05-12 | 2021-10-27 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF |
| CN112292386B (zh) | 2018-06-15 | 2024-06-11 | 百时美施贵宝公司 | 作为半乳凝素-3抑制剂的基于四氢吡喃的硫代二糖模拟物 |
-
2021
- 2021-05-04 US US17/921,653 patent/US12275720B2/en active Active
- 2021-05-04 CN CN202180033194.3A patent/CN115551855A/zh active Pending
- 2021-05-04 EP EP21727712.8A patent/EP4146646A1/en active Pending
- 2021-05-04 KR KR1020227042064A patent/KR20230006547A/ko active Pending
- 2021-05-04 JP JP2022567342A patent/JP7705884B2/ja active Active
- 2021-05-04 WO PCT/US2021/030540 patent/WO2021226002A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527395A5 (https=) | ||
| JP2022527075A5 (https=) | ||
| JP2021508686A5 (https=) | ||
| JP2019526582A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2020510664A5 (https=) | ||
| JP2021527102A5 (https=) | ||
| JP6824952B2 (ja) | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール | |
| JP7656669B2 (ja) | マトリックスメタロプロテイナーゼ（ｍｍｐ）阻害剤及びその使用方法 | |
| JP7577682B2 (ja) | ガレクチン－３の低分子阻害剤 | |
| JP2016517432A5 (https=) | ||
| JP2015509098A5 (https=) | ||
| JP2007508238A5 (https=) | ||
| JP2023533203A5 (https=) | ||
| JP2022545158A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JP2006513221A5 (https=) | ||
| JP2023524996A5 (https=) | ||
| JP2022545159A5 (https=) | ||
| JP2021505541A5 (https=) | ||
| EP1802606B1 (en) | Arylcarboxamides and their use as anti-tumor agents | |
| WO2007002637B1 (en) | N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions | |
| JP2023546742A5 (https=) | ||
| JP2023527396A5 (https=) | ||
| JP2023525527A5 (https=) |